DOASENSE GmbH -- Welcome - DOASENSE -- Pioneering Point-of-Care Testing for DOACs
Main menu:
DOASENSE at the ISTH 2017, Berlin
When every minute counts …
… fast DOAC testing matters.
DOASENSE’s mission objective is changing the landscape of testing for DOACs (new synthetic oral anticoagulants) with novel & quick point of care urine tests
A rapid assessment of the anticoagulant effect of non-vitamin K antagonist oral anticoagulants (Direct Oral AntiCoagulants – DOACs) by point of care testing (POCT) is an unmet clinical need:
- in specific patient populations, or under certain clinical circumstances
- for confirmation of compliance, or for patient self-testing
The determination of DOACs has long been limited to blood sampling approaches, with all their potential limitations.
DOASENSE™ develops products for specific testing for DOACs in urine
Tests which are easy to use and easy to interpret, reproducible, and patient friendly
Typical clinical scenarios where testing for specific DOACs can be of value
- Stroke (e.g. before thrombolytic therapy)
- Trauma
- Emergency procedures
- Evaluating for venous thromboembolism
- Spontaneous hemorrhage
- General surgery or invasive procedures (e.g. dental surgery)
- Other situations where medication history may not available
In each of these situations the objective is establishing the absence of DOACs in the patient prior to procedure
NOTE: DOASENSE(TM) products are not yet available.
